Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-13T06:43:39.507Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (April 2008)

Published online by Cambridge University Press:  01 July 2008

R Sutherland
R Sutherland
Affiliation:
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journals Watch
Information
Breast Cancer Online , Volume 11 , Issue 7 , July 2008 , e14
Copyright
Copyright © Cambridge University Press 2008

References

1.Ahmad, R, Raina, D, Meyer, C, Kufe, D. Triterpenoid CDDO-methyl ester inhibits the janus-activated kinase-1 (JAK1)→ Signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3. Cancer Res 2008; 68: 2920–2926.CrossRefGoogle ScholarPubMed
2.Antoniou, AC, Cunningham, AP, Peto, J, Evans, DG, Lalloo, F, Narod, SA, Risch, HA, Eyfjord, JE, Hopper, JL, Southey, MC, Olsson, H, Johannsson, O, Borg, A, Passini, B, Radice, P, Manoukian, S, Eccles, DM, Tang, N, Olah, E, Anton-Culver, H, Warner, E, Lubinski, J, Gronwald, J, Gorski, B, Tryggvadottir, L, Syrjakoski, K, Kallioniemi, OP, Eerola, H, Nevanlinna, H, Pharoah, PDP, Easton, DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 2008; 98: 1457–1466.CrossRefGoogle ScholarPubMed
3.Antoniou, AC, Spurdle, AB, Sinilnikova, OM, Healey, S, Pooley, KA, Schmutzler, RK, Versmold, B, Engel, C, Meindl, A, Arnold, N, Hofmann, W, Sutter, C, Niederacher, D, Deissler, H, Caldes, T, Kampjarvi, K, Nevanlinna, H, Simard, J, Beesley, J, Chen, XQ, Neuhausen, SL, Rebbeck, TR, Wagner, T, Lynch, HT, Isaacs, C, Weitzel, J, Ganz, PA, Daly, MB, Tomlinson, G, Olopade, OI, Bium, JL, Couch, FJ, Peterlongo, P, Manoukian, S, Barile, M, Radice, P, Szabo, CI, Pereira, LHM, Greene, MH, Rennert, G, Leibkowicz, F, Barnett-Griness, O, Andrulis, IL, Ozcelik, H, Gerdes, AM, Caligo, MA, Laitman, Y, Kaufman, B, Milgrom, R, Friedman, E, Domchek, SM, Nathanson, KL, Osorio, A, Llort, G, Milne, RL, Benitez, J, Hamann, U, Hogervorst, FBL, Manders, P, Ligtenberg, MJL, van den Ouweland, AMW, Peock, S, Cook, M, Platte, R, Evans, DG, Eeles, R, Pichert, G, Chu, C, Eccles, D, Davidson, R, Douglas, F, Godwin, AK, Barjhoux, L, Mazoyer, S, Sobol, H, Bourdon, V, Eisinger, F, Chompret, A, Capoulade, C, Paillerets, BBD, Lenoir, GM, Gauthier-Villars, M, Houdayer, C, Stoppa-Lyonnet, D, Easton, DF. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008; 82: 937–948.CrossRefGoogle ScholarPubMed
4.Bennett, HL, Brummer, T, Jeanes, A, Yap, AS, Daly, RJ. Gab2 and Src co-operate in human mammary epithelial cells to promote growth factor independence and disruption of acinar morphogenesis. Oncogene 2008; 27: 2693–2704.CrossRefGoogle ScholarPubMed
5.Caldon, CE, Swarbrick, A, Lee, CSL, Sutherland, RL, Musgrove, EA. The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini. Cancer Res 2008; 68: 3026–3036.CrossRefGoogle ScholarPubMed
6.Chan, SW, Lim, CJ, Guo, K, Ng, CP, Lee, I, Hunziker, W, Zeng, Q, Hong, WJ. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 2008; 68: 2592–2598.CrossRefGoogle ScholarPubMed
7.Crawford, NPS, Alsarraj, J, Lukes, L, Walker, RC, Officewala, JS, Yang, HH, Lee, MP, Ozato, K, Hunter, KW. Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci USA 2008; 105: 6380–6385.CrossRefGoogle ScholarPubMed
8.Descotes, F, Riche, B, Saez, S, De Laroche, G, Datchary, J, Roy, P, Andre, J, Bobin, JY. Plasminogen activator inhibitor type 1 is the most significant of the usual tissue prognostic factors in node-negative breast ductal adenocarcinoma independent of urokinase-type plasminogen activator. Clin Breast Cancer 2008; 8: 168–177.CrossRefGoogle ScholarPubMed
9.Dhakal, HP, Naume, B, Synnestvedt, M, Borgen, E, Kaaresen, R, Schlichting, E, Wiedswang, G, Bassarova, A, Giercksky, KE, Nesland, JM. Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination. Clin Cancer Res 2008; 14: 2341–2350.CrossRefGoogle ScholarPubMed
10.Diorio, C, Brisson, J, Berube, S, Pollak, M. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Biomarkers Prev 2008; 17: 880–888.CrossRefGoogle ScholarPubMed
11.Gilbert, JA, Goetz, MP, Reynolds, CA, Ingle, JN, Giordano, KF, Suman, VJ, Blair, HE, Jenkins, RB, Lingle, WL, Reinholz, MM, Adiei, AA, Ames, MM. Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy. Mol Cancer Ther 2008; 7: 944–951.CrossRefGoogle ScholarPubMed
12.Golden, T, Aragon, LV, Rutland, B, Tucker, JA, Shevde, LA, Samant, RS, Zhou, G, Amable, L, Skarra, D, Honkanen, RE. Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer. Biochim Biophys Acta-Mol Basis Dis 2008; 1782: 259–270.CrossRefGoogle ScholarPubMed
13.Horwitzt, KB, Dye, WW, Harrell, JC, Kabos, P, Sartorius, CA. Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts. Proc Natl Acad Sci USA 2008; 105: 5774–5779.CrossRefGoogle Scholar
14. Kendall A, Anderson H, Dunbier AK, Mackay A, Dexter T, Urruticoechea A, Harper-Wynne C, Dowsett M. Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivo. Cancer Epidemiol Biomarkers Prev 17:855–863.CrossRefGoogle Scholar
15.Ladoire, S, Arnould, L, Apetoh, L, Coudert, B, Martin, F, Chauffert, B, Fumoleau, P, Ghiringhelli, F. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating Foxp3(+) regulatory T cells. Clin Cancer Res 2008; 14: 2413–2420.CrossRefGoogle ScholarPubMed
16.Li, Y, Zhang, Y, Hill, J, Kim, HT, Shen, Q, Bissonnette, RP, Lamph, WW, Brown, PH. The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice. Br J Cancer 2008; 98: 1380–1388.CrossRefGoogle ScholarPubMed
17.Lubet, RA, Szabo, E, Christov, K, Bode, AM, Ericson, ME, Steele, VE, Juliana, MM, Grubbs, CJ. Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes. Mol Cancer Ther 2008; 7: 972–979.CrossRefGoogle ScholarPubMed
18.Newcomb, PA, Egan, KM, Trentham-Dietz, A, Titus-Ernstoff, L, Baron, JA, Hampton, JM, Stampfer, MJ, Willett, WC. Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 864–871.CrossRefGoogle ScholarPubMed
19.Pan, MR, Hou, MF, Chang, HC, Hung, WC. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells. J Biol Chem 2008; 283: 11155–11163.CrossRefGoogle ScholarPubMed
20.Sarkar, C, Chakroborty, D, Chowdhury, UR, Dasgupta, PS, Basu, S. Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models. Clin Cancer Res 2008; 14: 2502–2510.CrossRefGoogle ScholarPubMed
21.Serrati, S, Margheri, F, Fibbi, G, Cara, GD, Minafra, L, Pucci-Minafra, I, Liotta, F, Annunziato, F, Pucci, M, Del Rosso, M. Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. J Pathol 2008; 214: 545–554.CrossRefGoogle ScholarPubMed
22.Shai, A, Pitot, HC, Lambert, PF. p53 loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers. Cancer Res 2008; 68: 2622–2631.CrossRefGoogle ScholarPubMed
23.Shakya, R, Szabolcs, M, McCarthy, E, Ospina, E, Basso, K, Nandula, S, Murty, V, Baer, R, Ludwig, T. The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression. Proc Natl Acad Sci USA 2008; 105: 7040–7045.CrossRefGoogle ScholarPubMed
24.Sun, H, Berquin, IM, Owens, RT, O’Flaherty, JT, Edwards, IJ. Peroxisome proliferator-activated receptor γ-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Cancer Res 2008; 68: 2912–2919.CrossRefGoogle ScholarPubMed
25.Weng, SC, Kashida, Y, Kulp, SK, Wang, D, Brueggemeier, RW, Shapiro, CL, Chen, CS. Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor. Mol Cancer Ther 2008; 7: 800–808.CrossRefGoogle ScholarPubMed